RecallRadar

FDA Drug recall D-0018-2026

Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count (NDC 67877-513-05), c). 1000-count (NDC 67…

On 2025-10-22 the FDA classified a Class II recall of Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count (NDC 67877-513-05), c). 1000-count (NDC 67… by Ascend Laboratories, citing failed Dissolution Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0018-2026
ClassificationClass II
Statusongoing
Initiated2025-09-19
Published2025-10-22
Last updated2026-09-13 11:52 UTC
CompanyAscend Laboratories
DistributionUS

Product

Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count (NDC 67877-513-05), c). 1000-count (NDC 67877-513-10), Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.

Reason

Failed Dissolution Specifications

Identifiers

ndc67877-511-90
ndc67877-511-05
ndc67877-511-10
ndc67877-511-55
ndc67877-511-33
ndc67877-511-38
ndc67877-512-90
ndc67877-512-05
ndc67877-512-10
ndc67877-512-44
ndc67877-512-33
ndc67877-512-38
ndc67877-513-90
ndc67877-513-05
ndc67877-513-10
ndc67877-513-23
ndc67877-513-33
ndc67877-513-38
ndc67877-514-90
ndc67877-514-05
ndc67877-514-10
ndc67877-514-33
ndc67877-514-38
code_infoLot#: 25140933, Exp. Feb. 2027 Lot#: 25140477, Exp. Dec. 2026 Lot#: 24144254, Exp. Oct. 2026 Lot#: 24144163, Exp. Sep. 2026 Lot#: 24143995, Exp. Sep. 2026

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0018-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.